Anti-Müllerian hormone as an independent predictor of twin versus singleton pregnancy in fresh cycles

Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, 2011, The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting, Hum. Reprod., 26, 1270, 10.1093/humrep/der037 Blazar, 2011, Use of in-cycle antiMüllerian hormone levels to predict cycle outcome, Am. J. Obstet. Gynecol., 205, 223, 10.1016/j.ajog.2011.04.035 Bustillo, 1997, Imposing limits on the number of oocytes and embryos transferred: is it necessary/wise or naughty/nice?, Hum. Reprod., 12, 1616, 10.1093/oxfordjournals.humrep.a019599 Buyuk, 2011, Random anti-Müllerian hormone (AMH) is a predictor of ovarian response in women with elevated baseline early follicular follicle-stimulating hormone levels, Fertil. Steril., 95, 2369, 10.1016/j.fertnstert.2011.03.071 Cutting, 2008, Elective single embryo transfer: guidelines for practice British Fertility Society and Association of Clinical Embryologists, Hum. Fertil. (Camb.), 11, 131, 10.1080/14647270802302629 De Jonge, 1997, Embryo number for transfer should be regulated, Fertil. Steril., 68, 784, 10.1016/S0015-0282(97)00355-5 De Neubourg, 2006, Impact of a restriction in the number of embryos transferred on the multiple pregnancy rate, Eur. J. Obstet. Gynecol. Reprod. Biol., 124, 212, 10.1016/j.ejogrb.2005.08.023 Ebner, 2006, Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles, Hum. Reprod., 21, 2022, 10.1093/humrep/del127 Eldar-Geva, 2005, Dynamic assays of inhibin B, anti-Müllerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome, Hum. Reprod., 20, 3178, 10.1093/humrep/dei203 Elgindy, 2008, Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients, Fertil. Steril., 89, 1670, 10.1016/j.fertnstert.2007.05.040 Fanchin, 2007, Anti-Müllerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization, J. Clin. Endocrinol. Metab., 92, 1796, 10.1210/jc.2006-1053 Ficicioglu, 2006, Early follicular antiMüllerian hormone as an indicator of ovarian reserve, Fertil. Steril., 85, 592, 10.1016/j.fertnstert.2005.09.019 Gleicher, 2010, Anti-Müllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve, Fertil. Steril., 94, 2824, 10.1016/j.fertnstert.2010.04.067 Gnoth, 2008, Relevance of anti-Müllerian hormone measurement in a routine IVF program, Hum. Reprod., 23, 1359, 10.1093/humrep/den108 Irez, 2011, Different serum anti-Müllerian hormone concentrations are associated with oocyte quality, embryo development parameters and IVF–ICSI outcomes, Arch. Gynecol. Obstet., 284, 1295, 10.1007/s00404-011-1979-6 Kallen, 2010, Trends in delivery and neonatal outcome after in vitro fertilization in Sweden: data for 25 years, Hum. Reprod., 25, 1026, 10.1093/humrep/deq003 Karaki, 2002, Blastocyst culture and transfer: a step toward improved in vitro fertilization outcome, Fertil. Steril., 77, 114, 10.1016/S0015-0282(01)02939-9 Kissin, 2005, Multiple-birth risk associated with IVF and extended embryo culture: USA, 2001, Hum. Reprod., 20, 2215, 10.1093/humrep/dei025 Kwee, 2008, Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve, Fertil. Steril., 90, 737, 10.1016/j.fertnstert.2007.07.1293 La Marca, 2011, Anti-Müllerian hormone-based prediction model for a live birth in assisted reproduction, Reprod. Biomed. Online, 22, 341, 10.1016/j.rbmo.2010.11.005 Lawlor, 2012, Effect of age on decisions about the numbers of embryos to transfer in assisted conception: a prospective study, Lancet, 379, 521, 10.1016/S0140-6736(11)61267-1 Lee, 1996, Müllerian inhibiting substance in humans: normal levels from infancy to adulthood, J. Clin. Endocrinol. Metab., 81, 571 Li, 2010, Evaluating the performance of serum antiMüllerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine insemination, Fertil. Steril., 94, 2177, 10.1016/j.fertnstert.2009.12.059 Lie Fong, 2008, Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality?, Reprod. Biomed. Online, 16, 664, 10.1016/S1472-6483(10)60480-4 Luke, 2010, Practice patterns and outcomes with the use of single embryo transfer in the United States, Fertil. Steril., 93, 490, 10.1016/j.fertnstert.2009.02.077 Majumder, 2010, The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos, Eur. J. Obstet. Gynecol. Reprod. Biol., 150, 166, 10.1016/j.ejogrb.2010.02.029 Martin, 2007, Births: final data for 2005, Natl. Vital Stat. Rep., 56, 1 McIlveen, 2007, Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population, Hum. Reprod., 22, 778, 10.1093/humrep/del435 Milki, 2000, Comparison of blastocyst transfer with day 3 embryo transfer in similar patient populations, Fertil. Steril., 73, 126, 10.1016/S0015-0282(99)00485-9 Nardo, 2009, Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization, Fertil. Steril., 92, 1586, 10.1016/j.fertnstert.2008.08.127 Nelson, 2007, Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles – implications for individualization of therapy, Hum. Reprod., 22, 2414, 10.1093/humrep/dem204 Nyboe Andersen, 2009, Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE. The European IVF Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE), Hum. Reprod., 24, 1267, 10.1093/humrep/dep035 Penarrubia, 2005, Basal and stimulation day 5 anti-Müllerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist – gonadotropin treatment, Hum. Reprod., 20, 915, 10.1093/humrep/deh718 Practice Committee of the Society for Assisted Reproductive Technology and the American Society for Reproductive Medicine, 2004, Guidelines on the number of embryos transferred, Fertil. Steril., 82, S1, 10.1016/j.fertnstert.2004.07.937 Practice Committee of the American Society for Reproductive Medicine and Practice Committee of the Society for Assisted Reproductive Technology, 2009, Guidelines on number of embryos transferred, Fertil. Steril., 92, 1518, 10.1016/j.fertnstert.2009.08.059 Practice Committee of the Society for Assisted Reproductive Technology and Practice Committee of the American Society for Reproductive Medicine, 2012, Elective single-embryo transfer, Fertil. Steril., 97, 835, 10.1016/j.fertnstert.2011.11.050 Racowsky, 2000, The number of eight-cell embryos is a key determinant for selecting day 3 or day 5 transfer, Fertil. Steril., 73, 558, 10.1016/S0015-0282(99)00565-8 Riggs, 2011, Anti-Müllerian hormone serum levels predict response to controlled ovarian hyperstimulation but not embryo quality or pregnancy outcome in oocyte donation, Fertil. Steril., 95, 410, 10.1016/j.fertnstert.2010.07.1042 Schieve, 1999, Live-birth rates and multiple-birth risk using in vitro fertilization, JAMA: J. Am. Med. Assoc., 282, 1832, 10.1001/jama.282.19.1832 Seifer, 2007, Müllerian inhibiting substance is an ovarian growth factor of emerging clinical significance, Fertil. Steril., 88, 539, 10.1016/j.fertnstert.2007.02.014 Seifer, 2002, Early follicular serum Müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles, Fertil. Steril., 77, 468, 10.1016/S0015-0282(01)03201-0 Seifer, 2011, Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States, Fertil. Steril., 95, 747, 10.1016/j.fertnstert.2010.10.011 Silberstein, 2006, Müllerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology, Hum. Reprod., 21, 159, 10.1093/humrep/dei270 Singer, T., Noel, M., Huang, J.Y., Zaninovic, N., Davis, O., Liu, H., Rosenwaks, Z., 2011. Anti Müllerian hormone correlates with embryo morphology in IVF cycles. In: ASRM (Fertil. Steril.), p. S29. Smeenk, 2007, AntiMüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracytoplasmic sperm injection, Fertil. Steril., 87, 223, 10.1016/j.fertnstert.2006.06.019 Templeton, 1998, Reducing the risk of multiple births by transfer of two embryos after in vitro fertilization, N. Engl. J. Med., 339, 573, 10.1056/NEJM199808273390901 Van Royen, 2001, Calculating the implantation potential of day 3 embryos in women younger than 38 years of age: a new model, Hum. Reprod., 16, 326, 10.1093/humrep/16.2.326 Wang, 2010, The association between anti-Müllerian hormone and IVF pregnancy outcomes is influenced by age, Reprod. Biomed. Online, 21, 757, 10.1016/j.rbmo.2010.06.041 Weenen, 2004, Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment, Mol. Hum. Reprod., 10, 77, 10.1093/molehr/gah015 Wu, 2009, Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients, J. Assist. Reprod. Genet., 26, 383, 10.1007/s10815-009-9332-8 Wunder, 2008, Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection, Fertil. Steril., 90, 2203, 10.1016/j.fertnstert.2007.10.078